# Risk: __Limited efficacy against specific viruses__ (PBN__Risk_1512)

## Property: has_RiskSubject

* [occupants of commercial and healthcare facilities](../Stakeholder/PBN__Stakeholder_972)
* [residents of residential environments](../Stakeholder/PBN__Stakeholder_973)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskSource

* [ikner_continuously_2020](../Article/PBN__Article_246)

## Property: has_RiskName

Persistence of specific viruses and increased risk of infection transmission.

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskTechnology

* [advanced antiviral technologies](../Technology/PBN__Technology_792)
* [surface coatings](../Technology/PBN__Technology_793)

## Property: has_RiskOwner

* [researchers](../Stakeholder/PBN__Stakeholder_2)
* [technology developers](../Stakeholder/PBN__Stakeholder_763)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskDescription

Antiviral technologies such as surface coatings may not be effective against certain viruses, reducing their ability to prevent infection transmission.

## Property: has_RiskISO_Purpose

* [Safety and security](../RiskISO/PBN__RiskISO_Impact_0)

## Property: has_RiskMitigation

* [Research and development of antiviral technologies that are effective against a wider range of viruses.](../RiskMitigation/PBN__RiskMitigation_2038)

